Subversive Highlights InterCure's Q4 Estimated Unaudited Results and Provides Update on TSX Listing and Name Change
Subversive Highlights InterCure's Q4 Estimated Unaudited Results and Provides Update on TSX Listing and Name Change News provided by Share this article Share this article InterCure's Q4 Results Show Accelerated Growth, Continued Increase in Profitability, Operating Profit and Net Profit InterCure Establishes International Leadership Position and is On-Track to Complete the Transaction with SVX SPAC and Listing on Nasdaq SVX to Begin Trading on TSX Beginning February 26, 2021 TORONTO, Feb. 23, 2021 /PRNewswire/ - SUBVERSIVE ACQUISITION LP (NEO: SVX.U) (OTCQX: SBVRF) (" SVX") (previously Sub...
Source: prnewswire.com